SERA vs CSBR
Comparison between Sera Prognostics Inc Class A (SERA, Company) and Champions Oncology Inc (CSBR, Company).
Both SERA and CSBR are from the Healthcare sector.
5-Year PerformanceCSBR has outperformed SERA, delivering a return of -7.1% compared to -31.4%
SERA vs CSBR - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
SERA vs CSBR - Historical Returns
Returns include dividend reinvestment.
SERA vs CSBR - Annual Returns (2007 - 2026)
Returns include dividend reinvestment.
| Year | SERA | CSBR |
|---|---|---|
| 2026 | -38.33% | -6.16% |
| 2025 | -64.59% | -15.73% |
| 2024 | +36.35% | +48.01% |
| 2023 | +356.49% | +27.15% |
| 2022 | -83.57% | -46.82% |
| 2021 | -42.27% | -22.59% |
| 2020 | N/A | +32.56% |
| 2019 | N/A | +5.58% |
| 2018 | N/A | +94.28% |
| 2017 | N/A | +36.14% |
| 2016 | N/A | -33.07% |
| 2015 | N/A | -40.50% |
| 2014 | N/A | -58.33% |
| 2013 | N/A | +300.00% |
| 2012 | N/A | -60.00% |
| 2011 | N/A | -16.67% |
| 2010 | N/A | +12.50% |
| 2009 | N/A | -25.93% |
| 2008 | N/A | -20.00% |
| 2007 | N/A | +133.33% |
SERA vs CSBR Drawdown Comparison
The maximum drawdown for SERA was -91.10%, occurring on Dec 28, 2022. This drawdown has not yet recovered.
The maximum drawdown for CSBR was -94.13%, occurring on Sep 16, 2016. This drawdown has not yet recovered.
The current SERA drawdown is -85.81%. The current CSBR drawdown is -75.20%.
| Rank | SERA | CSBR |
|---|---|---|
| #1 | -91.10% Aug 9, 2021 - Dec 28, 2022 | -94.13% Oct 24, 2007 - Sep 16, 2016 |
| #2 | -23.11% Jul 15, 2021 - Aug 2, 2021 | -58.33% Feb 2, 2007 - May 31, 2007 |
| #3 | -8.00% Aug 2, 2021 - Aug 5, 2021 | -35.71% Jun 1, 2007 - Oct 10, 2007 |
| #4 | N/A | -12.71% Oct 18, 2007 - Oct 23, 2007 |
Correlation
Correlation between SERA and CSBR is 0.18 which considered as a very weak or no correlation - the stocks move independently of each other.
Select Stocks to Compare
More Comparisons
Compare with similar stocks